128 related articles for article (PubMed ID: 8010733)
1. Serum interleukin-6 levels in uterine malignancies. Preliminary data.
Ferdeghini M; Gadducci A; Prontera C; Bonuccelli A; Annicchiarico C; Fanucchi A; Facchini V; Bianchi R
Anticancer Res; 1994; 14(2B):735-7. PubMed ID: 8010733
[TBL] [Abstract][Full Text] [Related]
2. Serum CYFRA 21-1 assay in squamous cell carcinoma of the cervix.
Ferdeghini M; Gadducci A; Annicchiarico C; Prontera C; Malagnino G; Castellani C; Facchini V; Bianchi R
Anticancer Res; 1993; 13(5C):1841-4. PubMed ID: 7505543
[TBL] [Abstract][Full Text] [Related]
3. Serum soluble interleukin-2 receptor (sIL-2R) assay in cervical and endometrial cancer. Preliminary data.
Ferdeghini M; Gadducci A; Prontera C; Marrai R; Malagnino G; Annicchiarico C; Fioretti P; Bianchi R
Anticancer Res; 1993; 13(3):709-13. PubMed ID: 8317901
[TBL] [Abstract][Full Text] [Related]
4. Determination of serum levels of different cytokeratins in patients with uterine malignancies.
Ferdeghini M; Gadducci A; Prontera C; Castellani C; Annicchiarico C; Gagetti O; Facchini V; Bianchi R
Anticancer Res; 1994; 14(3B):1393-7. PubMed ID: 7520682
[TBL] [Abstract][Full Text] [Related]
5. Serum vascular endothelial growth factor C (VEGF-C) as a specific biomarker for advanced cervical cancer: Relationship to insulin-like growth factor II (IGF-II), IGF binding protein 3 (IGF-BP3) and VEGF-A [corrected].
Mathur SP; Mathur RS; Gray EA; Lane D; Underwood PG; Kohler M; Creasman WT
Gynecol Oncol; 2005 Sep; 98(3):467-83. PubMed ID: 15982726
[TBL] [Abstract][Full Text] [Related]
6. Cytokine profile in Indian women with cervical intraepithelial neoplasia and cancer cervix.
Sharma A; Rajappa M; Saxena A; Sharma M
Int J Gynecol Cancer; 2007; 17(4):879-85. PubMed ID: 17343606
[TBL] [Abstract][Full Text] [Related]
7. Serum vascular endothelial growth factor and serum leptin in patients with cervical cancer.
Lebrecht A; Ludwig E; Huber A; Klein M; Schneeberger C; Tempfer C; Koelbl H; Hefler L
Gynecol Oncol; 2002 Apr; 85(1):32-5. PubMed ID: 11925116
[TBL] [Abstract][Full Text] [Related]
8. High serum levels of interleukin-6 in endometrial carcinoma are associated with uterine serous papillary histology, a highly aggressive and chemotherapy-resistant variant of endometrial cancer.
Bellone S; Watts K; Cane' S; Palmieri M; Cannon MJ; Burnett A; Roman JJ; Pecorelli S; Santin AD
Gynecol Oncol; 2005 Jul; 98(1):92-8. PubMed ID: 15904949
[TBL] [Abstract][Full Text] [Related]
9. A panel of regulated proteins in serum from patients with cervical intraepithelial neoplasia and cervical cancer.
Boichenko AP; Govorukhina N; Klip HG; van der Zee AG; Güzel C; Luider TM; Bischoff R
J Proteome Res; 2014 Nov; 13(11):4995-5007. PubMed ID: 25232869
[TBL] [Abstract][Full Text] [Related]
10. Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases.
Riisbro R; Stephens RW; Brünner N; Christensen IJ; Nielsen HJ; Heilmann L; von Tempelhoff GF
Gynecol Oncol; 2001 Sep; 82(3):523-31. PubMed ID: 11520150
[TBL] [Abstract][Full Text] [Related]
11. Circulating soluble neuropilin-1 in patients with early cervical cancer and cervical intraepithelial neoplasia can be used as a valuable diagnostic biomarker.
Yang S; Cheng H; Huang Z; Wang X; Wan Y; Cai J; Wang Z
Dis Markers; 2015; 2015():506428. PubMed ID: 25873749
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of angiogenin (ANG) in invasive cervical cancer and in cervical intraepithelial neoplasia (CIN).
Bodner-Adler B; Hefler L; Bodner K; Leodolter S; Frischmuth K; Kainz C; Mayerhofer K
Anticancer Res; 2001; 21(1B):809-12. PubMed ID: 11299848
[TBL] [Abstract][Full Text] [Related]
13. Copper and zinc levels in serum from patients with abnormalities of the uterine cervix.
Grail A; Norval M
Acta Obstet Gynecol Scand; 1986; 65(5):443-7. PubMed ID: 3776486
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Value of Serum hsa-mir-92a in Patients with Cervical Cancer.
Kong Q; Tang Z; Xiang F; Jiang J; Yue H; Wu R; Kang X
Clin Lab; 2017 Feb; 63(2):335-340. PubMed ID: 28182350
[TBL] [Abstract][Full Text] [Related]
15. Distribution of Th17 cells and Foxp3-expressing T cells in tumor-infiltrating lymphocytes in patients with uterine cervical cancer.
Hou F; Li Z; Ma D; Zhang W; Zhang Y; Zhang T; Kong B; Cui B
Clin Chim Acta; 2012 Nov; 413(23-24):1848-54. PubMed ID: 22820395
[TBL] [Abstract][Full Text] [Related]
16. Serum C-reactive protein levels in patients with cervical neoplasia.
Wong F; Arumanayagam M; Swaminathan R; Chang A
Gynecol Obstet Invest; 1989; 27(3):166-8. PubMed ID: 2661362
[TBL] [Abstract][Full Text] [Related]
17. Circulating levels of insulin-like growth factor-II and IGF-binding protein 3 in cervical cancer.
Mathur SP; Mathur RS; Underwood PB; Kohler MF; Creasman WT
Gynecol Oncol; 2003 Dec; 91(3):486-93. PubMed ID: 14675666
[TBL] [Abstract][Full Text] [Related]
18. Serum IL-6 and micrometry of pap smears in women with cervical low-grade intraepithelial lesions.
Paradkar PH; Agashe SV; Joshi JV; Jagtap SS; Affandi MZ; Vaidya RA
Asian Pac J Cancer Prev; 2010; 11(4):989-92. PubMed ID: 21133612
[TBL] [Abstract][Full Text] [Related]
19. Serum alpha1 fetoprotein in gynecological malignancies.
Restaino A; Sabatini R; Amoruso A; Ferreri R; Selvaggi L
Eur J Gynaecol Oncol; 1981; 2(3):139-40. PubMed ID: 6182001
[No Abstract] [Full Text] [Related]
20. Concentration levels of IL-10 and TNFα cytokines in patients with human papilloma virus (HPV) DNA⁺ and DNA⁻ cervical lesions.
Ali KS; Ali HY; Jubrael JM
J Immunotoxicol; 2012; 9(2):168-72. PubMed ID: 22471745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
